Personalized Bioactive Extract Generation System

Publication ID: 24-11857587_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Bioactive Extract Generation System,” Published Technical Disclosure No. 24-11857587_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857587_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,587.

Summary of the Inventive Concept

A next-generation system that leverages machine learning, genetic profiling, and cloud-based databases to generate personalized bioactive extracts tailored to individual health needs, revolutionizing the field of medicinal fungal species-based compositions.

Background and Problem Solved

The original patent's composition and methods, although innovative, are limited by their one-size-fits-all approach. The present inventive concept addresses this limitation by introducing a personalized approach, recognizing that individual genetic profiles and health risks require customized bioactive extracts for optimal efficacy.

Detailed Description of the Inventive Concept

The system comprises a bioactive extract generator, a machine learning module, and a cloud-based database. The generator produces a personalized bioactive extract based on an individual's genetic profile, analyzed by the machine learning module to identify specific health risks. The system selects a medicinal fungal species, ferments it, and recommends a customized treatment plan. The composition includes a bioactive extract from a genetically engineered medicinal fungal species, designed to produce a specific combination of bioactive compounds tailored to an individual's health needs. A wearable device and cloud-based database enable continuous monitoring and adjustment of the treatment plan.

Novelty and Inventive Step

The inventive concept's novelty lies in its integration of machine learning, genetic profiling, and cloud-based databases to generate personalized bioactive extracts. The inventive step resides in the system's ability to analyze individual health data and recommend customized treatment plans, overcoming the limitations of traditional, non-personalized compositions.

Alternative Embodiments and Variations

Alternative embodiments may include mobile applications for health data tracking, integration with electronic health records, or the use of other types of machine learning algorithms. Variations may involve different types of medicinal fungal species, genetic engineering techniques, or wearable devices.

Potential Commercial Applications and Market

The personalized bioactive extract generation system has vast commercial potential in the pharmaceutical, nutraceutical, and wellness industries, targeting individuals seeking tailored health solutions. The system's ability to provide customized treatment plans and continuous monitoring can disrupt traditional healthcare models, offering a new paradigm for personalized medicine.

CPC Classifications

SectionClassGroup
A A61 A61K36/074
A A61 A61K36/185
A A61 A61K2236/333

Field of Art

Biotechnology and medicinal fungal extract compositions, specifically focused on personalized health interventions involving bioactive compounds derived from fungal species

Person of Ordinary Skill (PHOSITA) Profile

A biotechnology researcher with expertise in fungal extract processing, genetic engineering, machine learning applications in personalized medicine, and advanced bioactive compound extraction techniques

Obviousness Rationale

A PHOSITA would recognize that integrating machine learning, genetic profiling, and personalized extract generation represents a predictable technological progression from existing medicinal fungal extract methodologies. The source patent's foundational work on fungal extract compositions provides a clear technical framework that naturally suggests personalization and advanced processing techniques. The PTD's variations represent incremental technological improvements that would be obvious to a skilled practitioner seeking to enhance therapeutic specificity and treatment effectiveness.

Obvious Combinations & Variations

Source Patent Element
Fungal extract production method using specific medicinal fungal species like Ganoderma lucidium
PTD Variation
Genetic engineering of medicinal fungal species to produce targeted bioactive compounds
Obviousness Reasoning
Genetic modification of fungal species to enhance compound production is a known technique in biotechnology, representing a predictable application of standard genetic engineering principles
Source Patent Element
Composition with antiviral, antibacterial, and immune-boosting activities
PTD Variation
Machine learning-driven personalization of bioactive extract based on individual genetic profiles
Obviousness Reasoning
Tailoring therapeutic interventions to individual genetic characteristics is a standard approach in precision medicine, representing an obvious extension of existing compositional technologies
Source Patent Element
Extraction method involving ethanol dilution and mycelia processing
PTD Variation
Cloud-based database and continuous health monitoring for dynamic treatment adjustment
Obviousness Reasoning
Integration of digital health technologies with traditional extraction methods is a predictable technological convergence in modern personalized medicine
Source Patent Element
Fungal species grown on agricultural substrates like rice and wheat
PTD Variation
Wearable device integration for real-time health data collection and extract optimization
Obviousness Reasoning
Combining biological extract production with digital health monitoring represents an obvious technological progression using standard IoT and biotechnology techniques
Source Patent Element
Composition with multiple potential therapeutic activities
PTD Variation
Personalized bioactive extract generation system using multi-parameter health risk analysis
Obviousness Reasoning
Expanding therapeutic composition strategies through comprehensive health risk assessment is a logical and predictable enhancement of existing medicinal extract technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857587 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed personalized bioactive extract generation system and associated methods to be obvious variations of the prior art. The incremental technological advancements represented by machine learning, genetic profiling, and dynamic treatment optimization constitute predictable extensions of existing medicinal fungal extract composition methodologies, thereby rendering potential patent claims obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,587
TitleBioactive extract